prof. dr. J.P. (Jelle) Ruurda
Full Professor
- Department of Surgical Oncology
Contact
Side Activities
Chairman committee on healthcare evaluation FMS
Member of the board of the Dutch society for gastrointestinal surgery
Proctor Intuitive Surgical
Research Output (248)
The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer
Gertsen E. C., de Jongh C., Brenkman H. J.F., Mertens A. C., Broeders I. A.M.J., Los M., Boerma D., ten Bokkel Huinink D., van Leeuwen L., Wessels F. J., van Hillegersberg R., Ruurda J. P. jul 2020, In: European Journal of Surgical Oncology. 46 , p. 1247-1253
Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer:a prospective study with weekly MRI
Defize Ingmar L, Boekhoff Mick R, Borggreve Alicia S, van Lier Astrid L H M W, Takahashi Noriyoshi, Haj Mohammad Nadia, Ruurda Jelle P, van Hillegersberg Richard, Mook Stella, Meijer Gert J jul 2020, In: Acta Oncologica. 59 , p. 753-759
Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients
Schurink B., Mazza E., Ruurda J. P., Roeling T. A.P., Bleys R. L.A.W., van Hillegersberg R. 1 jun 2020, In: Surgical Oncology. 33 , p. 170-176 7 p.
3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy
Boekhoff M. R., Defize I. L., Borggreve A. S., Takahashi N., van Lier A. L.H.M.W., Ruurda J. P., van Hillegersberg R., Lagendijk J. J.W., Mook S., Meijer G. J. 1 jun 2020, In: Radiotherapy and Oncology. 147 , p. 1-7 7 p.
Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study
Kingma B. F., Rauwerdink P., Brenkman H. J.F., Ruurda J. P., van Hillegersberg R. 1 jun 2020, In: Journal of Cancer Survivorship. 14 , p. 253-260 8 p.
Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer:a propensity-matched analysis
Tagkalos E, Goense L, Hoppe-Lotichius M, Ruurda J P, Babic B, Hadzijusufovic E, Kneist W, van der Sluis P C, Lang H, van Hillegersberg R, Grimminger P P 15 apr 2020, In: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 33 6 p.
Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer
Borggreve Alicia S, Heethuis Sophie E, Boekhoff Mick R, Goense Lucas, van Rossum Peter S N, Brosens Lodewijk A A, van Lier Astrid L H M W, van Hillegersberg Richard, Lagendijk Jan J W, Mook Stella, Ruurda Jelle P, Meijer Gert J 1 apr 2020, In: European Radiology. 30 , p. 1896-1907 12 p.
Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma
Anderegg Martinus C J, Ruurda Jelle P, Gisbertz Suzanne S, Blom Rachel L G M, Sosef Meindert N, Wijnhoven Bas P L, Hulshof Maarten C C M, Bergman Jacques J G H M, van Laarhoven Hanneke W M, van Berge Henegouwen Mark I apr 2020, In: European Journal of Surgical Oncology. 46 , p. 626-631 6 p.
The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies
Busslinger Georg A, Lissendorp Fianne, Franken Ingrid A, van Hillegersberg Richard, Ruurda Jelle P, Clevers Hans, de Maat Michiel F G apr 2020, In: Open Biology. 10 6 p.
Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study
Gertsen Emma C, Goense Lucas, Brenkman Hylke J F, van Hillegersberg Richard, Ruurda Jelle P, mrt 2020, In: Gastric Cancer. 23 , p. 339-348 10 p.